Gabriel India Limited (GABRIEL)
Written Transcript for Analyst/Investor Meet held on July 22, 2026.
AI summary
- Gabriel India approved acquisition of 28.99% stake in HL Mando Anand for INR2,231 Cr and 30% minus 1 stake in HL Klemove for USD 98.44 million
- Q1 FY27 standalone revenue grew 19% to INR1,274 Cr; EBITDA up 7% to INR107 Cr; margin at 8.4%
- Consolidated revenue rose 15.5% to INR1,426 Cr; EBITDA grew 2% to INR124 Cr; margin at 8.7%
- HL Mando Anand FY26 turnover INR5,886 Cr, PAT INR358 Cr; HL Klemove FY26 revenue INR1,000 Cr+, EBITDA INR129 Cr
- Gabriel targets INR50,000 Cr revenue by 2030 across PV, CV, 2W, off-highway, and EV segments
- Regulatory tailwinds expected from safety norms and ADAS adoption
- Debt expected to rise to INR1,000 Cr with debt-equity ratio ~1:1 post transactions
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 GABRIEL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add GABRIEL to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Gabriel India Limited
Important.
The summary above is generated automatically from Gabriel India Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.